This inventor holds 1 USPTO granted patent and 6 EPO patents. Top assignee: Adaptate Biotherapeutics Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shefali Bhumbra - Innovator in Antibody Development
Introduction
Shefali Bhumbra is an accomplished inventor based in London, GB. She is currently associated with Gammadelta Therapeutics Ltd, where she focuses on the development of innovative therapeutic solutions. Despite having no granted patents to her name, her contributions to the field of antibody research are noteworthy.
Latest Patent Applications
Shefali Bhumbra's recent patent application is titled "ANTI-TCR DELTA VARIABLE 1 ANTIBODIES." This invention provides high-affinity anti-TCR delta variable 1 (anti-Vδ1) antibodies and antibody fragments. The application also details compositions and pharmaceutical formulations that include these antibodies, along with methods for their production. Furthermore, it outlines various treatment methods and medical applications involving these antibodies.
Conclusion
Shefali Bhumbra's work in antibody development showcases her commitment to advancing medical science, even in the absence of granted patents. Her innovative approach has the potential to contribute significantly to therapeutic advancements in the future.